8-KLeadership ChangesRegulation FD

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Feb 6, 2009)

Filed February 6, 2009For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) filed an 8-K on February 6, 2009, reporting two key events. The most significant for investors is the appointment of Kenneth I. Shine, M.D., as an independent director and his pending election by shareholders. Dr. Shine brings extensive experience in health affairs from his role at the University of Texas System. Despite the University of Texas System receiving approximately $251 million in payments from UNH in fiscal year 2008 for healthcare and network provider services, the company states that Dr. Shine had no interest in these transactions and they were conducted on an arm's-length basis. Additionally, the company announced that senior management will present the 2009 business outlook at the UBS 2009 Global Healthcare Services Conference on February 10, 2009. An audio webcast and the presentation slides will be made available on the company's investor website. Investors should note that this latter disclosure is made under Regulation FD and is not considered 'filed' for SEC reporting purposes.

Key Highlights

  • 1Appointment of Kenneth I. Shine, M.D., as an independent director to the Board of Directors.
  • 2Dr. Shine is recommended for election as a director at the upcoming 2009 Annual Meeting of Shareholders.
  • 3Dr. Shine's background includes serving as Executive Vice Chancellor for Health Affairs of the University of Texas System.
  • 4UnitedHealth Group made payments of approximately $251 million to the University of Texas System in fiscal year 2008 for network services.
  • 5The company confirmed Dr. Shine had no interest in these transactions, which were conducted at arm's length.
  • 6Senior management will present the 2009 business outlook at the UBS 2009 Global Healthcare Services Conference on February 10, 2009.
  • 7An audio webcast and presentation materials for the conference will be available on the company's investor website.

Frequently Asked Questions

Kenneth I. Shine, M.D., has been appointed as an independent director to the Board of Directors of UnitedHealth Group. He is also recommended for election by shareholders at the 2009 Annual Meeting.

Dr. Shine has significant experience in health affairs, having served as Executive Vice Chancellor for Health Affairs of the University of Texas System. While the University of Texas System received approximately $251 million from UnitedHealth Group in fiscal year 2008 for services, the company states that Dr. Shine had no interest in these transactions and they were negotiated on an arm's-length basis.

Senior management will be presenting the company's 2009 business outlook at the UBS 2009 Global Healthcare Services Conference on February 10, 2009, in New York. An audio webcast and the presentation slides will be available on the Investors page of UnitedHealth Group's website (www.unitedhealthgroup.com).

No, the information provided under Item 7.01 regarding the conference presentation is disclosed under Regulation FD and is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other SEC filings unless expressly stated.